Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

36.65
Delayed Data
As of 4:01pm ET
 +1.45 / +4.12%
Today’s Change
31.90
Today|||52-Week Range
59.35
+1.10%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 42.00, with a high estimate of 80.00 and a low estimate of 27.00. The median estimate represents a +14.60% increase from the last price of 36.65.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in Teva Pharmaceutical. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.36
Sales
$6.3B
Reporting Date
Feb 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.45%
 
 
 
 
 
 
Growthannually -5.65%
 
 
 
 
 
 

Sales

Growthquarterly 12.35%
 
 
 
 
 
 
Growthannually 9.98%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.